The M&A Advisor recently recognized Fried Frank for its role in the acquisition of Forest Laboratories by Actavis, which was named Healthcare/Life Sciences Deal of the Year as part of the 2014 Dealmakers Awards.
Fried Frank acted as counsel to Greenhill & Co. as financial advisor to Actavis plc in its approximately US$25 billion cash-and-stock acquisition of Forest Laboratories, Inc., a New York-based specialty pharmaceutical company with a portfolio of products and medicines focused on areas including the central nervous system, cardiovascular, gastrointestinal, respiratory, anti-infective and cystic fibrosis. Headquartered in Dublin, Ireland, Actavis is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.
Corporate partners Abigail Bomba and Philip Richter worked on the deal, which was announced in February 2014.
To learn more about the 2014 Dealmakers Awards, click here.